What is the story about?
Get ready, India! AI is making waves in the world of aging. OpenAI and Retro Biosciences have joined forces, and the results are stunning! GPT-4b micro is here, and it's changing the game.
AI's Cellular Leap
Artificial intelligence is moving beyond what we already know and exploring inside our cells. OpenAI created GPT-4b micro with Retro Biosciences. This AI focuses on protein sequences, biological literature, and 3D molecular structures. This could lead to breakthroughs in the field of medicine and biotechnology, changing lives.
Yamanaka Factor Reimagined
GPT-4b micro was used to redesign proteins, the Yamanaka factors, which led to a Nobel Prize. The AI generated new variants of these proteins, surpassing originals in the lab. Cells exposed to these factors showed a 50-fold higher expression of stem cell markers and repaired DNA damage faster.
Impressive Lab Results
In laboratory tests, these redesigned proteins achieved a greater than 50-fold higher expression of stem cell reprogramming markers than wild-type controls. The AI-created proteins made aged cells act young. This is a major step toward therapies that may delay or reverse human aging, offering new hope.
Future of Medicine
The potential of these advancements for longevity research and regenerative medicine is huge. The Yamanaka factors have been used to develop therapeutics to combat blindness, reverse diabetes, treat infertility, and address organ shortages. This is a pivotal moment where AI co-creates biological breakthroughs.
Do you find this article useful?
